ライフサイエンスコーパス: immunodiagnostic

1 aving the way for the next generation of POC immunodiagnostics.

2 e findings have expanded the field of cancer immunodiagnostics.

3 hly desirable for the design of vaccines and immunodiagnostics.

4 it provides a new avenue for high-throughput immunodiagnostics.

5 ll as their potential utility as targets for immunodiagnostic agents, is discussed.

6 The WHO-endorsed immunodiagnostic Alere Determine Lipoarabinomannan Ag-te

7 irst section of this review focuses on rapid immunodiagnostic and DNA-based detection methods for kno

8 ich known lipid antigens can be developed as immunodiagnostic and immunotherapeutic reagents for tube

9 ising concerns about use of these targets in immunodiagnostics and next-generation vaccines.

10 e widespread and include clinical chemistry, immunodiagnostics and protein analysis, cell handling, m

11 obes in microarray and biosensor technology, immunodiagnostics, and high-throughput screening.

12 pproach, including disease activity scoring, immunodiagnostics, and magnetic resonance imaging, as we

13 ally available EIAs (Abbott, Euroimmun, EDI, ImmunoDiagnostics, and Roche) for detection of IgG or to

14 approach was employed to identify candidate immunodiagnostic antigens.

15 ntial utility of polymer microprojections in immunodiagnostics applications.

16 We demonstrate the feasibility of an immunodiagnostic approach based on the detection of tau

17 An immunodiagnostic assay that sensitively detects a cell-m

18 tested negative for TB in the 38-kDa antigen immunodiagnostic assay were also tested for reactivity a

19 ncorporation of these biomarkers into future immunodiagnostic assays for TB could result in substanti

20 e to these potentially important vaccine and immunodiagnostic candidates is not known.

21 rmal/confirming results: culture/molecular + immunodiagnostic + chest radiography in 12 (27.9%) cases

22 tic + chest radiography in 12 (27.9%) cases, immunodiagnostic + chest radiography in 19 (44.2%) cases

23 Moreover, leading immunodiagnostic companies currently do not offer rapid

24 eir ability to work as reagents for enhanced immunodiagnostic detection.

25 significant challenges to the development of immunodiagnostics for detecting emergent viral variants.

26 nd IGF-2 makes serological discrimination by immunodiagnostic IGF tests a challenging task.

27 proteins with those molecular masses are of immunodiagnostic importance, Lyme disease patient sera w

28 est radiography in 2 (4.7%) cases, culture + immunodiagnostic in 1 (2.3%) case, chest radiography onl

29 MAb CLIA can be used to generate a sensitive immunodiagnostic kit, which offers the potential for a h

30 ring the relative ease of measuring RBP with immunodiagnostic kits compared with that of serum retino

31 ing used in the production of antibodies for immunodiagnostic kits.

32 development of prototype rapid lateral flow immunodiagnostic (LFI) assays that are true point-of-con

33 human vessels expressed GLUT-1 and merosin, immunodiagnostic markers for infantile hemangioma.

34 c inhibition immunoassay (TIIA) is a classic immunodiagnostic method that has been extensively used f

35 Since no established immunodiagnostic methods for penicilliosis marneffei are

36 Therefore, alternative immunodiagnostic methods, such as serological assays, ar

37 est radiography only in 8 (18.6%) cases, and immunodiagnostic only in 1 (2.3%) case.

38 have applications for many fields including immunodiagnostics, phage display library generation, and

39 hotonic crystal (PC) optical biosensor as an immunodiagnostic platform for detection of serum ferriti

40 We present an immunodiagnostic platform to detect this.

41 h potential application as a facile COVID-19 immunodiagnostic platform, which can be used to report t

42 in this work can be used for numerous other immunodiagnostic platforms which need further high-sensi

43 tum cDNA (GH17) that encodes an antigen with immunodiagnostic potential.

44 th the discovery of the prion protein (PrP), immunodiagnostic procedures were applied to diagnose Cre

45 ide-based molecular detection, Point-of-Care immunodiagnostics, radiographical analysis/sensing syste

46 assay based on the ratiometric plug-and-play immunodiagnostics (RAPPID) platform, with an improved in

47 s essential in medical applications, such as immunodiagnostic reagent discovery, vaccine design, and

48 implicifolia (GS-1-B(4)) has been used as an immunodiagnostic reagent.

49 re filtrates to develop subunit vaccines and immunodiagnostic reagents.

50 We anticipate that a T cell-based immunodiagnostic scheme to classify subjects based on th

51 These findings provide a baseline for future immunodiagnostic studies of lacritin in dry eye and othe

52 Current AAT empirical and immunodiagnostic surveillance tools suffer from poor sen

53 nce effectors, dominant T cell antigens, and immunodiagnostic targets.

54 used as the standard against which all other immunodiagnostic techniques are compared because an immu

55 Here we provide an immunodiagnostic technology platform that, to our knowle

56 hembio dual-path platform HIV-syphilis rapid immunodiagnostic test and electronic reader for detectio

57 e the laboratory performance of a dual rapid immunodiagnostic test for HIV and syphilis.

58 A rapid immunodiagnostic test that detects and discriminates hum

59 en should therefore include a combination of immunodiagnostic testing and imaging followed by culture

60 logy, immunohistochemical staining, specific immunodiagnostic testing, and COX1 gene sequencing, we w

61 the potential to improve the sensitivity of immunodiagnostic tests detecting bovine tuberculosis in

62 Immunodiagnostic tests may improve sensitivity, but thes

63 Point-of-care (POC) immunodiagnostic tests play a crucial role in enabling r

64 for the development of potential vaccines or immunodiagnostic tests.

65 This notion has profound implications for immunodiagnostics: the detection of apparently recall Ag

66 gy to facilitate the targeted development of immunodiagnostic tools.

67 binant proteins are also beginning to impact immunodiagnostics, with the promise of even more highly